The wealth of many of today's businesses comprises the collective knowledge and innovation of their employees and leaders. In the global economy, innovation has become as valuable as gold. Consequently intellectual property protection has become the focus of considerable legal and regulatory attention, at both an international and national level. Theft, piracy, and infringements on IP can be revealed at every level, from the state to the individual. Patents, Profits and Power examines the less desirable players on the world stage, why they choose to defy the law, and how the rest of the world is responding. The book also examines how the internet is changing the rules of intellectual property protection. It is packed with international case studies and examples to illustrate the impact of the internet on the development, control and protection of valuable ideas, products and services. This title will prove an invaluable reference source for anyone who is involved in protecting intellectual property.

Patents are powerful weapons in a company's legal arsenal, with both defensive and offensive capabilities. Patents protect a company's innovation from potential infringers, while at the same time support the company's efforts to exploit their innovation commercially in the global marketplace. This book explores the role of patents in today's knowledge economy. We discuss how patents have become a valuable commodity and have a lucrative market of their own. However, to profit from patent monetization, this Patent market must be closely linked to the R&D market and the Product Market.This book offers a systematic approach to patent deployment to maximize profits beginning with data collection from patent, journal and business sources. Readers will be guided through analyses of the patent landscape to identify traps and opportunities for commercialization. This book argues that patents must be aggregated into portfolios to maximize their effectiveness and value in the modern economy. With strong patent portfolios, companies can be engaged in licensing and more sophisticated business models like forming patent alliances and collaborating with IP intermediaries. Finally, the book will provide an overview of the various ways of valuing patents and suggest some simplified approaches for management to value the company's patents.

At head of title: 85th Cong., 2d sess. Committee print. Bibliography: p. 81-86.

Excerpt from Profit From Invention: Being Suggestions as to the Making of Practical Improvements in the Useful, Arts, Protecting Them by Letters Patent and Disposing of the Monopoly How to Invent. It may be thought that it is beginning unnecessarily near the foundation of things to discourse upon the manner of making inventions, in a little work, the main purpose of which is to outline reasonable methods to be followed in attempting to realize profit from undeveloped invention - that is, invention undeveloped in a commercial sense; but the realization of profit from an invention depends primarily and legitimately upon there being real value in it, upon its utility and practical character; and what is said under this head has largely for an object the suggestion of the ends to which invention should, in the first place, be directed in order to attain utility, practicability and, consequently, profit. It is beyond the power of these pages to literally teach how to invent; it is beyond the power of any mere form of language to do this. No mere words can endow a brain with the subtle and wonderful power of evolving from its inner self positive intellectual creations. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.

Through a collaboration among twenty legal scholars from North America, Europe and Asia, this book presents an international consensus on the use of patent remedies for complex products such as smartphones, computer networks, and the Internet of Things. This title is also available as Open Access on Cambridge Core.

Somebody owns your genes. Through the U.S. patent system, corporations and universities have claimed property rights not just on the rice and corn at your dinner table but also on you. Moving beyond patenting and "owning" diseases like staph, tuberculosis, and SARS, one American corporation owns the genetic heritage of the entire population of lceland. A university has property rights on all human clones -- even though human cloning is still being debated in Congress. Another company claims to have invented "junk" DNA. Through its patents, it stakes a claim to the research on 95% of human DNA. Profits Pending examines the devastating affects of these patents on life, from the blatant theft of cultural resources to slowing down research into deadly diseases. Once used to reward the inventiveness of American scientists and entrepreneurs, the patent system is now being abused to control scientific exploration into human biology and to create monopolies over the world's food sources. Instead of promoting scientific discoveries, patents on life now destroy crucial elements of the scientific method such as the free exchange of ideas between researchers. Profits Pending demonstrates that patents on life may ultimately destory the biotechnology industry and hinder the innovation the American economy depends on. Book jacket.

In The Global Politics of Pharmaceutical Monopoly Power, researcher and global advocate Ellen 't Hoen explains how new global rules for pharmaceutical patenting impact access to medicines in the developing world. The book gives an account of the current debates on intellectual property, access to medicines, and medical innovation, and provides historical context that explains how the current system emerged. This book supports major policy changes in the management of pharmaceutical patents and the way medical innovation is financed in order to protect public health and, in particular, promote access to essential medicines for all. The Open Society Institute provided support to translate this report into Russian.